scleteri TERIFLUNOMIDE

Introduction to scleteri

scleteri is a medication available in tablet form, primarily used to treat relapsing forms of multiple sclerosis. This condition occurs when the immune system attacks the protective covering of nerves, and scleteri helps reduce the frequency of relapses and slows the progression of physical disability.

Composition of scleteri

scleteri contains the active ingredient Teriflunomide, which works by inhibiting certain immune cells. This action reduces inflammation and slows the progression of multiple sclerosis by blocking the production of pyrimidine, a building block for DNA, thus limiting the growth of rapidly dividing cells like immune cells.

Uses of scleteri

• Treatment of relapsing forms of multiple sclerosis
• Reduction in the frequency of relapses
• Slowing the progression of physical disability

Side effects of scleteri

• Common side effects: hair thinning, diarrhea, nausea
• Serious side effects: liver damage, potential harm during pregnancy

Precautions of scleteri

scleteri can cause liver damage, so regular liver function tests are necessary. It is not recommended during pregnancy due to potential harm to the unborn baby. Always consult your doctor before starting scleteri to ensure it's safe for you.

How to Take scleteri

The usual starting dose of scleteri for adults is 14 mg once daily. It can be taken with or without food. Swallow the tablet whole; do not crush it. If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Follow your doctor’s advice for the correct way to use your prescribed form.

Conclusion of scleteri

scleteri, containing the active ingredient Teriflunomide, belongs to the therapeutic class of medications used to treat multiple sclerosis. It is manufactured to help reduce relapses and slow disability progression. Always consult your healthcare provider for personalized advice and regular monitoring. scleteri is a key medication for managing relapsing forms of multiple sclerosis effectively.